Literature DB >> 29045807

Evidence reversal-when new evidence contradicts current claims: a systematic overview review of definitions and terms.

Desirée Sutton1, Riaz Qureshi1, Janet Martin2.   

Abstract

OBJECTIVE: To explore the terminology and definitions surrounding the phenomenon of evidence reversal (ER)-which occurs when an existing claim is tested and the original evidence is contradicted by new and stronger evidence. STUDY DESIGN AND
SETTING: For this systematic overview review, multiple medical and gray literature databases were systematically searched from inception to 2016 as well as hand searches of relevant journals, websites, blogs, article bibliographies, citing articles, and related articles. All reviews directly and indirectly defining ER were included and rated for quality using AMSTAR.
RESULTS: A total of 87 articles met the inclusion criteria. Fifty unique sets of terms related to ER were identified: nine described the phenomenon of reversal; 17 described the consequences of reversal; 20 described targets; four described potential predictors of reversal.
CONCLUSION: ER has only recently become a topic of formal exploration. There are many terms that relate to the concept of reversal, which fall into the categories of phenomenon, consequences, targets, and potential predictors of reversal. Consensus should be reached on which terms are most appropriate such that subject headings can be developed and cohesion can be brought to this emerging field of meta-research. (PROSPERO Registration number: CRD42014013768).
Copyright © 2017 Elsevier Inc. All rights reserved.

Keywords:  Disinvestment; Evidence reversal; Evidence-based medicine; Evidence-based practice; Medical reversal; Standard of care reversals

Mesh:

Year:  2017        PMID: 29045807     DOI: 10.1016/j.jclinepi.2017.10.004

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  Prophylactic use of dural tenting sutures in elective craniotomies in adults-is it necessary? A study protocol for a multicentre, investigator- and participant-blinded randomised, parallel-group, non-inferiority trial.

Authors:  Przemysław Kunert; Łukasz Przepiórka; Jan Fortuniak; Karol Wiśniewski; Ernest Jan Bobeff; Patrycja Larysz; Rafał Kruk; Bartłomiej Kulesza; Dariusz Szczepanek; Piotr Ładziński; Jarosław Żyłkowski; Sławomir Kujawski; Kamila Łabędzka; Dariusz Jaskólski; Radosław Rola; Tomasz Trojanowski; Andrzej Marchel
Journal:  Trials       Date:  2021-04-12       Impact factor: 2.279

2.  The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009-2018.

Authors:  Alyson Haslam; Jennifer Gill; Tyler Crain; Diana Herrera-Perez; Emerson Y Chen; Talal Hilal; Myung S Kim; Vinay Prasad
Journal:  BMC Cancer       Date:  2021-08-03       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.